TetraLogic Pharmaceuticals Corporation
TLOG · OTC
9/30/2016 | 6/30/2016 | 3/31/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Market Cap | $4 | $8 | $4 | $43 |
| - Cash | $6 | $9 | $15 | $15 |
| + Debt | $31 | $30 | $29 | $28 |
| Enterprise Value | $29 | $29 | $19 | $56 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$9 | -$5 | -$9 | -$13 |
| % Margin | – | – | – | – |
| Net Income | -$9 | -$8 | -$13 | -$16 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.35 | -0.34 | -0.51 | -0.64 |
| % Growth | -2.9% | 33.3% | 20.3% | – |
| Operating Cash Flow | -$3 | -$6 | -$6 | -$9 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$3 | -$6 | -$6 | -$9 |